Paper28490751
Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.
Anderson LL and 4 others. Sci Rep, 2017. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome. Papers, record 28490751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28490751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epilepsies, Myoclonic | Major topic |
| NAV1.1 Voltage-Gated Sodium Channel | Major topic |
| Pyridines | Major topic |
| Triazoles | Major topic |
| Action Potentials | |
| Animals | |
| Ion Channel Gating | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| NAV1.6 Voltage-Gated Sodium Channel | |
| Neurons | |
| Pyramidal Cells | |
| Seizures | |
| Survival Analysis |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS032387 | NINDS NIH HHS | United States | R01NS032387 | PubMed and NIH | NIH RePORTER |
| R01 NS084959 | NINDS NIH HHS | United States | R01NS084959 | PubMed and NIH | NIH RePORTER |
| R37 NS032387 | NINDS NIH HHS | United States | R01NS032387 | PubMed and NIH | NIH RePORTER |
| R37NS032387 | NIH | NIH RePORTER |
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26680203 | Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. | Science | 2015 | https://conductscience.org/library/papers/26680203 | PubMed |
| 2 | 17537961 | Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. | J Neurosci | 2007 | https://conductscience.org/library/papers/17537961 | PubMed |
| 3 | 23772876 | Cav 2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo. | Epilepsia | 2013 | https://conductscience.org/library/papers/23772876 | PubMed |
| 4 | 26900580 | Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy. | Ann Clin Transl Neurol | 2016 | https://conductscience.org/library/papers/26900580 | PubMed |
| 5 | 21453355 | SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs. | Epilepsia | 2011 | https://conductscience.org/library/papers/21453355 | PubMed |
| 6 | 27080178 | Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/27080178 | PubMed |
| 7 | 26966048 | Pharmacotherapy for Dravet Syndrome. | Paediatr Drugs | 2016 | https://conductscience.org/library/papers/26966048 | PubMed |
| 8 | 24862204 | Antiepileptic activity of preferential inhibitors of persistent sodium current. | Epilepsia | 2014 | https://conductscience.org/library/papers/24862204 | PubMed |
| 9 | 25666511 | The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome. | Epilepsy Behav | 2015 | https://conductscience.org/library/papers/25666511 | PubMed |
| 10 | 23934111 | De novo mutations in epileptic encephalopathies. | Nature | 2013 | https://conductscience.org/library/papers/23934111 | PubMed |
| 11 | 12086636 | Molecular basis of an inherited epilepsy. | Neuron | 2002 | https://conductscience.org/library/papers/12086636 | PubMed |
| 12 | 26482210 | Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26482210 | PubMed |
| 13 | 21832094 | Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21832094 | PubMed |
| 14 | 16921370 | Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. | Nat Neurosci | 2006 | https://conductscience.org/library/papers/16921370 | PubMed |
| 15 | 23010360 | A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. | J Pharmacol Exp Ther | 2013 | https://conductscience.org/library/papers/23010360 | PubMed |
| 16 | 24225340 | Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. | Orphanet J Rare Dis | 2013 | https://conductscience.org/library/papers/24225340 | PubMed |
| 17 | 17928448 | Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. | J Neurosci | 2007 | https://conductscience.org/library/papers/17928448 | PubMed |
| 18 | 24463883 | Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. | Hum Mol Genet | 2014 | https://conductscience.org/library/papers/24463883 | PubMed |
| 19 | 25281316 | Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome. | Neurobiol Dis | 2015 | https://conductscience.org/library/papers/25281316 | PubMed |
| 20 | 27136942 | Use-Dependent Block of Human Cardiac Sodium Channels by GS967. | Mol Pharmacol | 2016 | https://conductscience.org/library/papers/27136942 | PubMed |
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42470359 | Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). II. Treatments in more advanced clinical development. | Epilepsia | 2026 | https://conductscience.org/library/papers/42470359 | PubMed |
| 42358368 | Cenobamate in pediatric Dravet syndrome: two responder cases highlighting the limits of simple "sodium-channel blocker" labeling. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42358368 | PubMed |
| 42257687 | Compensatory rearrangement of parvalbumin interneuron voltage-gated sodium channel subunits in a mouse model of Dravet syndrome. | Epilepsia | 2026 | https://conductscience.org/library/papers/42257687 | PubMed |
| 41752003 | Functional Coupling Between Voltage-Dependent Sodium Channels and Activation of the Ca2+ Signaling That Mediates Endothelial Cell Migration. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752003 | PubMed |
| 41331425 | Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41331425 | PubMed |
| 40848130 | Microglial activation is inhibited by selective anti-seizure medications. | Inflamm Res | 2025 | https://conductscience.org/library/papers/40848130 | PubMed |
| 40808385 | Voltage-gated sodium channels in the nervous system: Molecular physiology to therapeutic interventions. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40808385 | PubMed |
| 40772259 | Dravet syndrome: novel insights into SCN1A-mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework. | Front Neurosci | 2025 | https://conductscience.org/library/papers/40772259 | PubMed |
| 40650012 | Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650012 | PubMed |
| 40586768 | Development of a preclinical testing platform for clinically relevant therapy for Dravet syndrome. | Epilepsia | 2025 | https://conductscience.org/library/papers/40586768 | PubMed |
| 40583701 | [Guideline for the diagnosis and treatment of common neonatal diseases in primary healthcare institutions: neonatal seizures (2025)]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | https://conductscience.org/library/papers/40583701 | PubMed |
| 40530598 | SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications. | Epilepsia Open | 2025 | https://conductscience.org/library/papers/40530598 | PubMed |
| 39513870 | Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies. | Cells | 2024 | https://conductscience.org/library/papers/39513870 | PubMed |
| 39212337 | Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome. | Epilepsia | 2024 | https://conductscience.org/library/papers/39212337 | PubMed |
| 38967655 | Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers. | Pflugers Arch | 2024 | https://conductscience.org/library/papers/38967655 | PubMed |
| 38547067 | Brainstem depolarization-induced lethal apnea associated with gain-of-function SCN1AL263V is prevented by sodium channel blockade. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38547067 | PubMed |
| 38430092 | Cardiac-Specific Deletion of Scn8a Mitigates Dravet Syndrome-Associated Sudden Death in Adults. | JACC Clin Electrophysiol | 2024 | https://conductscience.org/library/papers/38430092 | PubMed |
| 38203200 | Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203200 | PubMed |
| 36811143 | Ictal vocalizations in the Scn1a+/- mouse model of Dravet syndrome. | Epilepsia Open | 2023 | https://conductscience.org/library/papers/36811143 | PubMed |
| 35625015 | Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling. | Brain Sci | 2022 | https://conductscience.org/library/papers/35625015 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SCN1A | 6323 | PubTator's text mining | https://conductscience.org/library/genes/6323 | NCBI Gene |
| SCN8A | 6334 | PubTator's text mining | https://conductscience.org/library/genes/6334 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28490751
GET https://conductscience.org/api/papers/v1/28490751/references?page=2